SIRT1 and glomerulosclerosis: Furthermore, the Sirt1 activator NMN—an NAD+-dependent deacetylase enhancer—improves podocyte injury and glomerulosclerosis by upregulating Sirt1 and the NAD+ salvage pathway, including Nampt and Nmnat1.